Microlyse

N/A

Report date: 2026/03/11 20:02:12
First In Class

Base Information

Drug NameMicrolyse
Drug Alias NameTGD-001
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUrokinase plasminogen activator stimulantsVon willebrand factor inhibitors
TargetsUrokinase plasminogen activatorVon willebrand factor
Therapy Area/IndicationsIschemic StrokeThrombotic MicroangiopathiesThrombocytopenia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Medical Centre Utrecht, Netherlands
China Registration ClassN/A

Develop Information

Active CompaniesTargED Biopharmaceuticals BV
Inactive CompaniesUniversity Medical Centre Utrecht, Netherlands
Active IndicationsIschemic StrokeThrombotic MicroangiopathiesThrombocytopenia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A